<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="courier ; font-style : italic;} BMC Infect DisBMC Infect. DisBMC" exact="Infectious" post="Diseases1471-2334BioMed CentralLondon pmcid: 72164175042 doi: 10.1186/s12879-020-05042-2 : Research Article"/>
 <result pre="University, [7], grid.174567.60000 0000 8902 2273Vietnam Research Station, Center for" exact="Infectious" post="Disease Research in Asia and Africa, Institute of Tropical"/>
 <result pre="[7], grid.174567.60000 0000 8902 2273Vietnam Research Station, Center for Infectious" exact="Disease" post="Research in Asia and Africa, Institute of Tropical Medicine,"/>
 <result pre="Between 2016 and 2019, 265 cases of Zika virus (ZIKV)" exact="infection" post="were reported in Vietnam, predominantly in southern Vietnam. In"/>
 <result pre="predominantly in southern Vietnam. In 2016, a case of ZIKV-associated" exact="microcephaly" post="was confirmed in the Central Highlands, and several members"/>
 <result pre="2016, a case of ZIKV-associated microcephaly was confirmed in the" exact="Central" post="Highlands, and several members of the infant’s family were"/>
 <result pre="the general population of the ZIKV epidemic region. Methods A" exact="total" post="of 879 serum samples were collected from 801 participants"/>
 <result pre="on the samples that ZIKV neutralizing antibody positive. Results A" exact="total" post="of 83 (10.3%) participants had anti-ZIKV IgM. Of the"/>
 <result pre="lived in the same village as the infant with ZIKV-associated" exact="microcephaly" post="and the other 4 lived in 2 neighboring communes."/>
 <result pre="1.5 years after the first collection. No new cases of ZIKV" exact="infection" post="were detected. In addition, 2 of 3 participants with"/>
 <result pre="low levels of circulation together with low seroprevalence suggests a" exact="limited" post="outbreak in the region, the results also reflect on"/>
 <result pre="and demonstrate a need for implementation of more effective ZIKV" exact="infection" post="control measures. Keywords Zika virus Zika virus infection Seroprevalence"/>
 <result pre="more effective ZIKV infection control measures. Keywords Zika virus Zika" exact="virus infection" post="Seroprevalence Seroepidemiologic studies Neutralizing antibodies Vietnam Funding http://dx.doi.org/10.13039/100009619Japan Agency"/>
 <result pre="effective ZIKV infection control measures. Keywords Zika virus Zika virus" exact="infection" post="Seroprevalence Seroepidemiologic studies Neutralizing antibodies Vietnam Funding http://dx.doi.org/10.13039/100009619Japan Agency"/>
 <result pre="body fluids [4]. Common symptoms are rash, fever, arthralgia, and" exact="conjunctivitis" post="[5]. While ZIKV infection is sometimes associated with only"/>
 <result pre="symptoms are rash, fever, arthralgia, and conjunctivitis [5]. While ZIKV" exact="infection" post="is sometimes associated with only mild symptoms, it can"/>
 <result pre="mild symptoms, it can also lead to severe complications including" exact="Guillain-Barré syndrome" post="[6] and microcephaly in infants [7]. The first reported"/>
 <result pre="symptoms, it can also lead to severe complications including Guillain-Barré" exact="syndrome" post="[6] and microcephaly in infants [7]. The first reported"/>
 <result pre="also lead to severe complications including Guillain-Barré syndrome [6] and" exact="microcephaly" post="in infants [7]. The first reported ZIKV epidemic occurred"/>
 <result pre="of Micronesia, in 2007, with an estimated 5000 of a" exact="total" post="of 6800 residents infected [5]. The second reported epidemic"/>
 <result pre="increase in the number of cases of infants born with" exact="microcephaly" post="suspected to be associated with ZIKV [7, 10]. According"/>
 <result pre="cases were only reported in 1977 [13]. In 2016, a" exact="total" post="of 455 cases were confirmed in Singapore [14] and,"/>
 <result pre="2015 to 2017 [15]. During this period, cases of ZIKV" exact="infection" post="were also reported in other Southeast Asia nations including"/>
 <result pre="[17]. In 2016, 3 tourists were confirmed to have ZIKV" exact="infection" post="after visiting Vietnam [18–20]. As of June 2019, a"/>
 <result pre="infection after visiting Vietnam [18–20]. As of June 2019, a" exact="total" post="of 265 cases has been reported in Vietnam, most"/>
 <result pre="Minh City [21–24]. Additionally, in 2016, a case of Zika-associated" exact="microcephaly" post="was reported in the Central Highlands of Vietnam and"/>
 <result pre="2016, a case of Zika-associated microcephaly was reported in the" exact="Central" post="Highlands of Vietnam and 5 family members and 2"/>
 <result pre="family members and 2 neighbors were confirmed positive for ZIKV" exact="infection" post="[25]. Despite the endemicity for dengue and the high"/>
 <result pre="density of mosquito vectors, the numbers of cases of ZIKV" exact="infection" post="in Vietnam remain substantially lower than the number of"/>
 <result pre="numbers of cases of ZIKV infection in Vietnam remain substantially" exact="lower" post="than the number of cases of dengue. Vietnam lies"/>
 <result pre="areas have reported ZIKV outbreaks in recent years, there are" exact="limited" post="data available on the extent of ZIKV infection in"/>
 <result pre="there are limited data available on the extent of ZIKV" exact="infection" post="in local populations in Vietnam. Additionally, it has been"/>
 <result pre="size of ZIKV epidemics in Southeast Asia. However, there were" exact="limited" post="seroprevalence data to support this hypothesis. Cross-reactivity between ZIKV"/>
 <result pre="approximately 100,000 dengue cases. The incidence of dengue has remained" exact="stable" post="over the past few decades in Vietnam [27], and"/>
 <result pre="dengue seroprevalence remains high, with up to 64% of the" exact="adult" post="population being seropositive [28]. Recent studies have suggested that"/>
 <result pre="is cross-reactive with ZIKV, the level of cross-neutralization and hence" exact="disease" post="protection is limited [29–31]. In Vietnam, the number of"/>
 <result pre="ZIKV, the level of cross-neutralization and hence disease protection is" exact="limited" post="[29–31]. In Vietnam, the number of ZIKV infections peaked"/>
 <result pre="protection is limited [29–31]. In Vietnam, the number of ZIKV" exact="infections" post="peaked at 219 in 2016, and has subsequently decreased,"/>
 <result pre="Buk District, Dak Lak Province where a case of ZIKV-associated" exact="microcephaly" post="had been reported [25]. The population density in this"/>
 <result pre="density in this region is 181 people/km2 with the estimated" exact="total" post="population of 65,000 living in an area of 357.82 km2."/>
 <result pre="of 357.82 km2. In January 2017, 3 months after the case of" exact="microcephaly" post="was reported, blood samples were collected from healthy adults"/>
 <result pre="District. None of the study participants were hospitalized for an" exact="acute" post="illness during the study period. In this study, we"/>
 <result pre="this study, we estimated the proportion of persons with ZIKV" exact="infection" post="in Krong Buk District. The required sample size was"/>
 <result pre="in-house ZIKV IgM ELISA kit. This method was adapted from" exact="Dengue" post="Virus IgM Capture DxSelect (Focus Diagnostics, Cypress, CA, USA)"/>
 <result pre="wash buffer solution for 5 min, and wells were decanted. A" exact="total" post="of 100 μL of diluted serum sample was added and"/>
 <result pre="were then washed with 1X wash buffer solution for a" exact="total" post="of 3 times to remove excess antigen. Next, 100 μL"/>
 <result pre="incubated at RT for 10 mins in the dark. A" exact="total" post="of 100 μL of stop solution (1 M sulfuric acid) was"/>
 <result pre="virus-complex mixture was then incubated at 37 °C for 1 h. A" exact="total" post="of 50 μL of virus-immune complex mixture was then added"/>
 <result pre="higher compare to DENV titers. The interpretation of probable ZIKV" exact="infection" post="was according to WHO guidelines for laboratory testing for"/>
 <result pre="was according to WHO guidelines for laboratory testing for Zika" exact="virus infection" post="in which samples that were positive for ZIKV IgM"/>
 <result pre="according to WHO guidelines for laboratory testing for Zika virus" exact="infection" post="in which samples that were positive for ZIKV IgM"/>
 <result pre="(CIs) were used to estimate the relative likelihood of ZIKV" exact="infection" post="in each group. Multiple logistic regression was used to"/>
 <result pre="estimate the relative likelihood of ZIKV infection in each group." exact="Multiple" post="logistic regression was used to assess the association of"/>
 <result pre="age group between 16 and 60 years (n = 663 or 82.7%). A" exact="total" post="of 87 samples were collected from children under the"/>
 <result pre="determine antibody levels of 83 samples, for the presence or" exact="absence of" post="anti-ZIKV IgM antibodies. All participants who tested positive were"/>
 <result pre="16 1 (6.3) 1/1 (100) 1/1 (100) 1/16 (6.3) Sex" exact="Female" post="590 59 (10) 1.00 (Reference) 0.57 32/59 (54.2) 10/64"/>
 <result pre="34/58 (58.6) 14/62(22.6) 10/503 (2.0) Otherb 8 0 0/8 (0.0)" exact="Pregnancy" post="66 1 (1.5) 0/1(0.0) 0/1(0.0) 0/66 (0.0) CI confidence"/>
 <result pre="analysis Fig. 1 Seroprevalence of Zika virus (ZIKV) antibodies in" exact="Central" post="Vietnam, 2017–2018. The seroprevalence of Zika virus antibodies according"/>
 <result pre="virus antibodies according to (a) age and (b) ethnicity. A" exact="total" post="of 83 participants (83/801, 10.3%) demonstrated anti-ZIKV IgM antibodies"/>
 <result pre="determined by using plaque-reduction neutralization test (PRNT) and for confirming" exact="infection" post="to ZIKV. Prevalence rates (anti-DENV IgG antibodies and anti-ZIKV"/>
 <result pre="and anti-ZIKV NS1 IgG antibodies) was determined by using a" exact="total" post="of 83 samples and 88 samples, respectively All 83"/>
 <result pre="(59.0%) ZIKV IgM positive cases were detected as positive for" exact="Dengue" post="IgG ELISA (Table 1). DENV IgM and DENV IgG"/>
 <result pre="(Z120a, Z138a, Z140a, Z420a, Z476a) were classified as probable ZIKV" exact="infections" post="(PRNT50 ZIKV = 1: 40–1: 640). Table 2 Anti-Zika virus immunoglobulin"/>
 <result pre="virus NS1 immunoglobulin G levels in cases of probable Zika" exact="virus infection" post="Levels of anti-ZIKV NS1 IgG antibodies in the 83"/>
 <result pre="NS1 immunoglobulin G levels in cases of probable Zika virus" exact="infection" post="Levels of anti-ZIKV NS1 IgG antibodies in the 83"/>
 <result pre="Systems). Anti-ZIKV NS1 IgG assays are useful for confirming ZIKV" exact="infection" post="because they are highly specific and possess minimal cross-reactivity"/>
 <result pre="anti-NS1 antibodies with a P/N ratio of 4.5. Finally, a" exact="total" post="of 19 samples demonstrated anti-ZIKV NS1 IgG antibodies, including"/>
 <result pre="and Z153) lived in Cu Pong commune. An infant with" exact="microencephaly" post="and her immediate family members has been confirmed confirmed"/>
 <result pre="immediate family members has been confirmed confirmed positive for ZIKV" exact="infection" post="in the Cu Pong commune in 2016 [25]. This"/>
 <result pre="(ZIKV) antibody seroprevalence in the survey districts, Dak Lak Province," exact="Central" post="Vietnam. Zika virus seroprevalence was determined by testing serum"/>
 <result pre="Star (★) indicates Cu Pong commune, in which a ZIKV-associated" exact="microencephaly" post="case has been detected in 2016. Image was created"/>
 <result pre="ZIKV neutralizing antibodies (PRNT = 1:40–1:640) with 3 cases exposed to ZIKV" exact="infection" post="confirmed using PRNT50 with ZIKV neutralizing titer ≥4fold of"/>
 <result pre="of DENVs neutralizing titer. While anti-IgM ZIKV antibodies may have" exact="lower" post="specificity than other laboratory assays, the test is useful"/>
 <result pre="ZIKV cases during an outbreak [32, 39]. Due to relatively" exact="short" post="detection window for ZIKV IgM antibodies, a combination of"/>
 <result pre="rates across age groups, indicating that the risk of ZIKV" exact="infection" post="is homologous across different age groups. In contrast, a"/>
 <result pre="ZIKV epidemic, the results also suggest that DENV may offer" exact="limited" post="cross-protection against ZIKV. Among the participants, there was no"/>
 <result pre="ZIKV IgM seroprevalence according to sex. The higher percentage of" exact="female" post="participants in this study is due to socioeconomic factors"/>
 <result pre="study is due to socioeconomic factors in this region, as" exact="adult" post="males have a higher tendency to travel for employment"/>
 <result pre="minority ethnic groups. This may reflect as increased risk of" exact="infectious disease" post="exposure due to ethnic and socio-economical associated activity and"/>
 <result pre="ethnic groups. This may reflect as increased risk of infectious" exact="disease" post="exposure due to ethnic and socio-economical associated activity and"/>
 <result pre="indicate local ZIKV transmission within the healthy community in the" exact="Central" post="Highlands of Vietnam. Overall, 9/801 (1.1%) of the ZIKV"/>
 <result pre="Cu Pong village, the same commune with the case of" exact="microcephaly" post="cases that we reported in the previous study. In"/>
 <result pre="respectively. This result indicates that the circulation of ZIKV in" exact="Central" post="Vietnam is limited in the period of 2 years since"/>
 <result pre="indicates that the circulation of ZIKV in Central Vietnam is" exact="limited" post="in the period of 2 years since the confirmation of"/>
 <result pre="The low ZIKV seroprevalence, a proxy of protection against the" exact="disease" post="in the community, however indicates that the community is"/>
 <result pre="risk of subsequent ZIKV epidemic. Conclusion This study confirms ZIKV" exact="infection" post="in the Central Highlands of Vietnam and suggests that"/>
 <result pre="ZIKV epidemic. Conclusion This study confirms ZIKV infection in the" exact="Central" post="Highlands of Vietnam and suggests that ZIKV has been"/>
 <result pre="1.1% at the start of the study period, suggesting a" exact="limited" post="outbreak within the area. Economic factors including migrant workers"/>
 <result pre="high in the region, the overall low ZIKV seroprevalence indicate" exact="limited" post="Zika disease protection in the population. Further studies of"/>
 <result pre="the region, the overall low ZIKV seroprevalence indicate limited Zika" exact="disease" post="protection in the population. Further studies of seroprevalence in"/>
 <result pre="potential risk of ZIKV transmission in the region. Abbreviations DENV" exact="Dengue" post="virus ELISA Enzyme-linked immunosorbent assay IgG Immunoglobulin G IgM"/>
 <result pre="under Grant Number JP19fm0108001(Japan Initiative for Global Research Network on" exact="Infectious" post="Diseases (J-GRID), AMED JP20wm0125006; and AMED Research on Emerging"/>
 <result pre="Grant Number JP19fm0108001(Japan Initiative for Global Research Network on Infectious" exact="Diseases" post="(J-GRID), AMED JP20wm0125006; and AMED Research on Emerging and"/>
 <result pre="(J-GRID), AMED JP20wm0125006; and AMED Research on Emerging and Re-emerging" exact="Infectious" post="Diseases (19fk0108109h0001, 20fk0108109h0001, 20fk0108123h1101) and Nagasaki University. The funders"/>
 <result pre="AMED JP20wm0125006; and AMED Research on Emerging and Re-emerging Infectious" exact="Diseases" post="(19fk0108109h0001, 20fk0108109h0001, 20fk0108123h1101) and Nagasaki University. The funders had"/>
 <result pre="Yap Island, Federated States of MicronesiaN Engl J Med20093602536254310.1056/NEJMoa080571519516034 6.KandelNLamichhaneJTangermannRHRodierGRDetecting" exact="Guillain-Barré syndrome" post="caused by Zika virus using systems developed for polio"/>
 <result pre="Island, Federated States of MicronesiaN Engl J Med20093602536254310.1056/NEJMoa080571519516034 6.KandelNLamichhaneJTangermannRHRodierGRDetecting Guillain-Barré" exact="syndrome" post="caused by Zika virus using systems developed for polio"/>
 <result pre="Guillain-Barré syndrome caused by Zika virus using systems developed for" exact="polio" post="surveillanceBull World Health Organ20169470570810.2471/BLT.16.17150427708476 7.TeixeiraMGda CNCMde OliveiraWKNunesMLRodriguesLCThe Epidemic of"/>
 <result pre="developed for polio surveillanceBull World Health Organ20169470570810.2471/BLT.16.17150427708476 7.TeixeiraMGda CNCMde OliveiraWKNunesMLRodriguesLCThe" exact="Epidemic" post="of Zika Virus-Related Microcephaly in Brazil: Detection, Control, Etiology,"/>
 <result pre="World Health Organ20169470570810.2471/BLT.16.17150427708476 7.TeixeiraMGda CNCMde OliveiraWKNunesMLRodriguesLCThe Epidemic of Zika Virus-Related" exact="Microcephaly" post="in Brazil: Detection, Control, Etiology, and Future ScenariosAm J"/>
 <result pre="Southeast AsiaEpidemiol Health201638e201602610.4178/epih.e201602627336445 13.OlsonJGKsiazekTGSuhandimanTZika virus, a cause of fever in" exact="Central" post="Java, IndonesiaTrans R Soc Trop Med Hyg19817538939310.1016/0035-9203(81)90100-06275577 14.HoZJMHapuarachchiHCBarkhamTChowANgLCLeeJMVet al.Outbreak"/>
 <result pre="IndonesiaTrans R Soc Trop Med Hyg19817538939310.1016/0035-9203(81)90100-06275577 14.HoZJMHapuarachchiHCBarkhamTChowANgLCLeeJMVet al.Outbreak of Zika" exact="virus infection" post="in Singapore: an epidemiological, entomological, virological, and clinical analysisLancet"/>
 <result pre="R Soc Trop Med Hyg19817538939310.1016/0035-9203(81)90100-06275577 14.HoZJMHapuarachchiHCBarkhamTChowANgLCLeeJMVet al.Outbreak of Zika virus" exact="infection" post="in Singapore: an epidemiological, entomological, virological, and clinical analysisLancet"/>
 <result pre="observational studyLancet Infect Dis20191943944610.1016/S1473-3099(18)30718-730826189 16.WoonYLLimMFTg Abd RashidTRThayanRChidambaramSKSyed Abdul RahimSSet al.Zika" exact="virus infection" post="in Malaysia: an epidemiological, clinical and virological analysisBMC Infect"/>
 <result pre="studyLancet Infect Dis20191943944610.1016/S1473-3099(18)30718-730826189 16.WoonYLLimMFTg Abd RashidTRThayanRChidambaramSKSyed Abdul RahimSSet al.Zika virus" exact="infection" post="in Malaysia: an epidemiological, clinical and virological analysisBMC Infect"/>
 <result pre="17.Myat Ngwe TunMKyaw KyawAWut HmoneSInoueSBueranoCCMin SoeAet al.Detection of Zika Virus" exact="Infection" post="in MyanmarAm J Trop Med Hyg201898SS10.4269/ajtmh.17-0708 18.MeltzerELustigYLeshemELevyRGottesmanGWeissmannRet al.Zika virus"/>
 <result pre="Infection in MyanmarAm J Trop Med Hyg201898SS10.4269/ajtmh.17-0708 18.MeltzerELustigYLeshemELevyRGottesmanGWeissmannRet al.Zika virus" exact="disease" post="in traveler returning from Vietnam to IsraelEmerg Infect Dis2016221521152210.3201/eid2208.16048027331627"/>
 <result pre="Thuong NV, Hung PC, Huong TTLN, et al. Fetal Zika" exact="virus infection" post="in Vietnam. PLoS Curr. 2017;9. 10.1371/currents.outbreaks.1c8f631e0ef8cd7777d639eba48647fa. 23.QuyenNTHKienDTHRabaaMTuanNMViTTVan TanLet al.Chikungunya"/>
 <result pre="NV, Hung PC, Huong TTLN, et al. Fetal Zika virus" exact="infection" post="in Vietnam. PLoS Curr. 2017;9. 10.1371/currents.outbreaks.1c8f631e0ef8cd7777d639eba48647fa. 23.QuyenNTHKienDTHRabaaMTuanNMViTTVan TanLet al.Chikungunya"/>
 <result pre="Ho Chi Minh City, VietnamInt J Gynecol Obstet201814139039110.1002/ijgo.12456 25.MoiMLNguyenTTTNguyenCTVuTBHTunMMNPhamTDet al.Zika" exact="virus infection" post="and microcephaly in VietnamLancet Infect Dis20171780580610.1016/S1473-3099(17)30412-728741545 26.HayesEBZika virus outside"/>
 <result pre="Chi Minh City, VietnamInt J Gynecol Obstet201814139039110.1002/ijgo.12456 25.MoiMLNguyenTTTNguyenCTVuTBHTunMMNPhamTDet al.Zika virus" exact="infection" post="and microcephaly in VietnamLancet Infect Dis20171780580610.1016/S1473-3099(17)30412-728741545 26.HayesEBZika virus outside"/>
 <result pre="City, VietnamInt J Gynecol Obstet201814139039110.1002/ijgo.12456 25.MoiMLNguyenTTTNguyenCTVuTBHTunMMNPhamTDet al.Zika virus infection and" exact="microcephaly" post="in VietnamLancet Infect Dis20171780580610.1016/S1473-3099(17)30412-728741545 26.HayesEBZika virus outside AfricaEmerg Infect"/>
 <result pre="Oliveira-FilhoEFFernandesAIBritoCAMarquesETTenórioMCet al.Previous dengue or Zika virus exposure can drive to" exact="infection" post="enhancement or neutralisation of other flavivirusesMem Inst Oswaldo Cruz201911417"/>
 <result pre="Zika virus and its relation to other Flaviviruses: implications for" exact="infection" post="and Immunoprophylaxis. Microbiol Mol Biol Rev. 2017;81. 10.1128/MMBR.00055-16. 32.WijesooriyaSLNguyenCTNguyenTTTVuTBHTaichiroTMoritaKet"/>
 <result pre="in medical studiesGastroenterol Hepatol from bed to bench201361417 34.Focus Diagnostics." exact="Dengue" post="Virus IgM Capture DxSelect TM (OUS). http://www.focusdx.com/pdfs/pi/OUS/EL1500M-OUS.pdf. Accessed 28"/>
 <result pre="of arboviral infectionsJ Clin Microbiol2000381823182610.1128/JCM.38.5.1823-1826.200010790107 37.PhamHVDoanHTPhanTTTran MinhNNEcological factors associated with" exact="dengue fever" post="in a central highlands provinceVietnam BMC Infect Dis20111117210.1186/1471-2334-11-17221679398 38.R&amp;amp;D"/>
 <result pre="https://www.rndsystems.com/products/human-anti-zika-virus-igg-elisa-kit_zik00. Accessed 3 Feb 2020. 39.WHO. Laboratory testing for Zika" exact="virus infection." post="World Heal Organ. 2016;1. 10.1038/sj.mp.4001048. 40.Van LeTThi Tuyet VanNHoang"/>
 <result pre="2016;1. 10.1038/sj.mp.4001048. 40.Van LeTThi Tuyet VanNHoang QuanNThoDPPhylogeny of dengue virus" exact="type 2" post="isolated in the central highlandsVietnam Rev Biol Trop201765819826 41.Van"/>
 <result pre="central highlandsVietnam Rev Biol Trop201765819826 41.Van TuanLVanNTTThiPNgaTDuongLQuanMet al.Seasonal distribution of" exact="dengue fever" post="in the central highlands region, Vietnam (2010- 2015)Am J"/>
</results>
